A new Lancet study warns liver cancer cases could nearly double by 2050, if no action is taken. The authors emphasise ...

AbbVie, Gilead Sciences and GSK marked World Hepatitis Day on Monday, outlining the need to tackle the stigma and discrimination associated with the group of viruses to eliminate them as a public ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

Delhi-NCR hospitals report a 40 per cent surge in hepatitis A and E cases this monsoon. Experts warn poor sanitation, unsafe ...

Surveillance of hepatocellular carcinoma (HCC), via 6-monthly ultrasonography with alpha-fetoprotein testing, is currently ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

While South Africa has made strides in testing and treating infectious diseases like HIV, HPV, and TB, there is a group of ...

Experts say there are several vaccines adults should get, depending on your age, lifestyle, and medical history. Here, ...

Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

Despite decades of interventions, Hepatitis B virus (HBV) remains prevalent in India. AIIMS experts emphasize the need for ...

Chronic hepatitis B (CHB) affects more than 254 million people globally, with 1.2 million new infections occurring each year.

Delhi-NCR faces a seasonal surge in hepatitis A and E cases, exacerbated by monsoon conditions. Experts highlight the ...